You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy

Article metrics

Article menu
XML
Basic tumor immunology
Original research
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy

 

Online download statistics by month:

Online download statistics by month: November 2020 to July 2025

AbstractFullPdf
Nov 2020401401151
Dec 202030130182
Jan 202113013094
Feb 2021666625
Mar 2021616130
Apr 2021666629
May 2021565625
Jun 2021575742
Jul 2021474731
Aug 2021525235
Sep 2021434333
Oct 2021949450
Nov 2021767745
Dec 2021313317
Jan 2022424417
Feb 2022303227
Mar 2022616734
Apr 2022606116
May 2022697129
Jun 2022545741
Jul 2022535315
Aug 2022676717
Sep 2022535531
Oct 2022303123
Nov 2022313111
Dec 202222229
Jan 202316169
Feb 2023535315
Mar 2023323441
Apr 2023212132
May 2023282816
Jun 2023323317
Jul 2023171715
Aug 2023272717
Sep 2023333316
Oct 202327276
Nov 2023232314
Dec 2023363621
Jan 2024232417
Feb 2024242417
Mar 2024474944
Apr 2024383926
May 2024394015
Jun 2024494823
Jul 2024373820
Aug 20244542165
Sep 2024222213
Oct 2024414122
Nov 2024676937
Dec 2024363624
Jan 2025282818
Feb 202511511528
Mar 2025414236
Apr 2025636341
May 2025535423
Jun 2025191915
Jul 2025110
Total318632171762